Brown leatherette covered hinged case with gray flocked interior. Insets in interior hold a green and silver colored metal and plastic insulin pen. Interior of case also has insets to hold insulin ...
Marks approval of first concentrated mealtime insulin analog in the U.S. and expands Lilly's portfolio of medicines for people with type 1 and type 2 diabetes INDIANAPOLIS, May 27, 2015 /PRNewswire/ - ...
INDIANAPOLIS, Ind.– Indianapolis-based Eli Lilly and Company announced plans Tuesday to offer two of its insulin pens for half the cost of the branded versions. The two pens will be lower-priced ...
Nine months after announcing that it will make a half-priced version of one of its liquid insulins, Eli Lilly and Co. has said it will offer less expensive versions of two of its popular insulin pens, ...
Drugmaker Eli Lilly & Co is announcing a temporary shortage of two of its insulin products. "The 10 mL [millilter] vials of Humalog and Insulin Lispro Injection are or will be temporarily out of stock ...
Humalog insulin pens. (Photo for The Washington Post by Jenn Ackerman) Eli Lilly will cut prices for some older insulins later this year and immediately expand a cap on costs insured patients pay to ...
Companion Medical, a stealthy San Diego-based company that received funding last year from Eli Lilly and Company, has received FDA 510(k) clearance for its Bluetooth-connected smart insulin pen and ...
Please provide your email address to receive an email when new articles are posted on . Eli Lilly and Co. will donate at least 200,000 KwikPens to three relief organizations to stock insulin at nearly ...
Katy Folven never leaves home without her insulin pen, but the busy Boston social worker sometimes forgets to track her daily doses. Limited time: Save 25% on NBC News subscription Get exclusive ...
Patients may have trouble finding two different types of insulin products made by Eli Lilly. The company said it's experiencing a shortage of its 10 mL vials of Humalog and Insulin Lispro Injection ...
Drugmaker Eli Lilly warned this week that two of its formulations of insulin would be temporarily out of stock through the beginning of April, citing a “brief delay in manufacturing.” The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results